Bradley Foster & Sargent Inc Adaptive Biotechnologies Corp Transaction History

Bradley Foster & Sargent Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Mar 11, 2022	SELL	$25.17 - $36.85 $1.56 Million - $2.29 Million	-62,126 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$30.02 - $39.87 $23,595 - $31,337	786 Added 1.28%	62,126 $2.11 Million
Q2 2021 Aug 19, 2021	SELL	$32.22 - $44.59 $1,739 - $2,407	-54 Reduced 0.09%	61,340 $2.51 Million
Q1 2021 Apr 26, 2021	BUY	$37.26 - $67.74 $1.47 Million - $2.68 Million	39,565 Added 181.25%	61,394 $2.47 Million
Q4 2020 Feb 11, 2021	BUY	$45.01 - $65.47 $209,341 - $304,500	4,651 Added 27.08%	21,829 $1.29 Million
Q3 2020 Oct 26, 2020	BUY	$35.79 - $48.81 $614,800 - $838,458	17,178 New	17,178 $835,000

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $726M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

Stay updated on Bradley Foster & Sargent Inc with notifications on news.